跳至主要内容
临床试验/NCT05706298
NCT05706298招募中不适用

The Effect of Interrupting Sitting With Regular Active Breaks on Glycaemia and Daily Insulin Dose in Sedentary People With Type 1 Diabetes

Liverpool John Moores University2 个研究点 分布在 1 个国家目标入组 118 人开始时间: 2022年12月7日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
118
试验地点
2
主要终点
Change in time in target glycaemic range

研究概览

简要总结

the investigators aim to determine the effect of 4 weeks of frequent active breaks from prolonged sitting on time in target glycaemic range in people with type 1 diabetes with high habitual sedentary behaviour.

详细描述

An open-label randomised controlled trial, whereby participants will complete pre-randomisation baseline procedures before allocation to 4wks of habitual activity (control) or active breaks. Interstitial glucose concentrations (fGM), insulin dose and physical activity/ postural transitions (ActivPAL) will be monitored throughout. To improve generalisability and feasibility of recruiting the required number of participants, the study will be completed in a free-living environment using remote data collection methods.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 66 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • T1D diagnosis more than 3 years ago
  • Sedentary (> 10h per waking day sedentary (sitting or lying)
  • Using insulin therapy with multiple daily injections or insulin pump
  • Aged 18-66 (UK retirement age)
  • Use of Abbot FreeStyle Libre 2 fGM (>6 weeks to avoid potential lifestyle changes as a result of sensor use)

排除标准

  • Engaged in structured planned exercise (e.g. running, cycling, gym, or sports)
  • Pregnancy or planning to become pregnant
  • <6 months postpartum or stopped breastfeeding <1 month before recruitment
  • Existing cerebrovascular or cardiovascular disease
  • Significant history of hyperglycaemia (HbA1c >85 mmol/mol)
  • History of severe hypoglycaemia requiring third party assistance within the last 3 months

结局指标

主要结局

Change in time in target glycaemic range

时间窗: change from baseline to final week of the intervention

flash glucose monitoring

次要结局

  • Change in BMI(change from baseline to post intervention (4 weeks))
  • Change in insulin dose(change from baseline to final week of the intervention)
  • Change in waist circumference(change from baseline to post intervention (4 weeks))
  • Change in glycaemic variability (coefficient of variation)(change from baseline to final week of the intervention)
  • Change in Concentration of Hba1c(change from baseline to post intervention (4 weeks))
  • Change in weight(change from baseline to post intervention (4 weeks))
  • Change in sedentary behaviour(change from baseline to final week of the intervention)
  • Change in Health-related quality of life(change from baseline to post intervention (4 weeks))
  • Change in Anxiety and depression(change from baseline to post intervention (4 weeks))
  • c-peptide(baseline)
  • Change in carbohydrate intake(change from baseline to final week of the intervention)
  • Change in Height(change from baseline to post intervention (4 weeks))
  • Change Insulin to CHO ratio(change from baseline to post intervention (4 weeks))
  • Change in Diabetes Quality of Life(change from baseline to post intervention (4 weeks))
  • Change in triglycerides.(change from baseline to post intervention (4 weeks))
  • Change in Insulin Sensitivity Score(change from baseline to post intervention (4 weeks))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验